Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    TopAbstracts in Diabetes 11/24/2009 - (DGNews)
    TopAbstracts in Diabetes 11/17/2009 - (DGNews)
    Darbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA - (DGDispatch)
    Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial - (BMJ)
    Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials - (BMJ)

    News archive

     Recent webcasts/CME - Diabetes
      Diabetes and the Heart: Diabetes and Glycemic Control - Endocrine
      Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Diabetes and the Heart: Cardiometabolic Screening and Hospital Care
      Diabetes and the Heart: Diabetes and Glycemic Control - Cardiovascular
      Diabetes and the Heart: Cardiac Care for the Patient with Diabetes: Clinical Horizons

      Webcasts/CME archive

       Recent cases - Diabetes
        Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Beta Cell Destruction In Type 1 Diabetes May Be More Extended In Females Than Males

        A DGReview of :"Is the process of beta cell destruction in type 1 diabetes at time of diagnosis more extended in females than in males?"
        European Journal of Endocrinology

        12/14/2001
        By Veronica Rose


        Beta cell destruction at diagnosis may be more extended in post-pubertal females than in males, according to researchers.

        However, while both genders exhibit similar metabolic parameters following the introduction of insulin, more insulin is required by females to achieve good metabolic control three months after diagnosis.

        Researchers from Rome, Italy, London, England and the United States, having noted that diabetes type 1 can be diagnosed at any age, sought evaluation of gender differences by a comparison of the integrated parameters of metabolic control at the point of clinical diagnosis and three months following intensive insulin therapy in pre-pubertal, pubertal and post pubertal patients.

        Participants included 331 consecutive patients with newly diagnosed type 1 diabetes mellitus. The mean age of the group was 15 years plus/minus 8.1 s.d (age-range five to 23 years). They were stratified according to age at onset of diabetes in three groups. These included pre-pubertal (aged five to nine years), pubertal (ages 10-18) and post-pubertal (19 to 23 years old).

        The researchers evaluated glycosylated haemoglobin, insulin dose and both basal and glucagon stimulated C-peptide at diagnosis, and again following three months of insulin therapy. A lower basal C-peptide was noted in females diagnosed after puberty by comparison with males, but no statistically significant differences were noted for other metabolic parameters say researchers.

        Females had a significantly lower BMI, a lower basal C-peptide, higher HbAlc and required more insulin than males. Three months following therapy, only females had a notably higher insulin dose, with similar good metabolic control as assesses by HbAlc, researchers concluded.
        European Journal of Endochrinology Dec 2001. "Is the process of beta cell destruction in type 1 diabetes at time of diagnosis more extended in females than in males?"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send